Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze BCRX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BCRX investment potential.

What is BCRX stock price today?

Get real-time BCRX stock price, historical data, and price charts on Financhill. Track BCRX performance with our advanced analysis tools.

Is BCRX a good investment?

Evaluate BCRX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BCRX stock?

To buy BCRX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BCRX?

View detailed market capitalization data and company valuation metrics for BCRX on our comprehensive analysis page.

What is the P/E ratio of BCRX?

Use our fundamental analysis tools to view BCRX P/E ratio and compare valuation metrics with industry peers.

What are BCRX earnings?

View BCRX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

BioCryst Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

BCRX
BioCryst Pharmaceuticals, Inc.

Last Price:

$7.46

Seasonality Move:

6.23%

7 Day Trial

ALL ACCESS PASS

$ 7

BioCryst Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 67.1% based on the past 31 years of stock performance.
BioCryst Pharmaceuticals, Inc. has risen higher in 14 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.16%
Is BioCryst Pharmaceuticals, Inc. Stock Undervalued?

The current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $7.45. The Score for BCRX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
BCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will BioCryst Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 67.1% based on the past 31 years of stock performance.

BioCryst Pharmaceuticals, Inc. Stock Rating

Buy

BioCryst Pharmaceuticals, Inc. (BCRX) is a Buy

Is BioCryst Pharmaceuticals, Inc. overpriced?

BioCryst Pharmaceuticals, Inc. has risen higher in 14 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.16%

BioCryst Pharmaceuticals, Inc. Stock Price History

Is BCRX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

biocryst.com

52-Week Data

52-Week High:

11.31

52-Week Low:

6.00

Prediction Charts

Market Cap:

1.8B

Price in USD:

7.45

Volume:

2.6M

Beta:

1.66

Technical Analysis

SMA50:

7.12

SMA100:

7.13

SMA200:

8.11

52-Wk Change:

-20.66%

Stock Predictions

Is BioCryst Pharmaceuticals, Inc. stock public?

Yes, BioCryst Pharmaceuticals, Inc. is a publicly traded company.
What is the BioCryst Pharmaceuticals, Inc. stock quote today?

The BioCryst Pharmaceuticals, Inc. stock price is 7.45 USD today.
How to buy BioCryst Pharmaceuticals, Inc. stock online?

You can buy BioCryst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Feb-2	6.55	6.63	6.75	6.47
Feb-3	6.61	6.70	6.75	6.55
Feb-4	6.72	6.42	6.76	6.40
Feb-5	6.44	6.24	6.57	6.23
Feb-6	6.44	6.38	6.44	6.26
Feb-9	6.34	6.30	6.38	6.26
Feb-10	6.31	6.55	6.64	6.30
Feb-11	6.53	6.84	6.91	6.46
Feb-12	6.82	6.80	6.86	6.61
Feb-13	6.87	6.76	6.91	6.72
Feb-17	6.78	6.95	7.01	6.76
Feb-18	6.97	7.26	7.36	6.97
Feb-19	7.26	7.48	7.48	7.16
Feb-20	7.47	7.45	7.50	7.31

BioCryst Pharmaceuticals, Inc. Earnings

BioCryst Pharmaceuticals, Inc. Earnings Report: Per Share BioCryst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

BioCryst Pharmaceuticals, Inc. Forecast Revenue Growth

BioCryst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $0.31 per share.

* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.